Multiple Sclerosis Clinical Trial
Official title:
Reproductibility of Cystometry in Multiple Sclerosis Patient
Verified date | February 2018 |
Source | Pierre and Marie Curie University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study evaluates the reproductibility (quantitative and qualitative) of cystometry in mutiple sclerosis patients.
Status | Completed |
Enrollment | 31 |
Est. completion date | January 1, 2018 |
Est. primary completion date | November 1, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: - All patient with Multiple Sclerosis referred for urinary disorders, - coming for a urodynamic evaluation with multiple cystometries during the study - detrusor overactivity for a filling of 300 ml or less on the first cystometry. Exclusion Criteria: - significate difference between the filling volume during the study and the volume truly of water truly collected after catheterization, - an urinary tract infection, - an other acute disease. |
Country | Name | City | State |
---|---|---|---|
France | Service de Neuro-urology, hôpital Tenon | Paris |
Lead Sponsor | Collaborator |
---|---|
Pierre and Marie Curie University |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reproductibility of urodynamic Capacity Cystometric Maximum (CCM) | Reproductibility of Capacity cystometric maximum (in ml) in the three cystometries evaluated using an intra class correlation | 1 Day : during the urodynamic assessment | |
Primary | Reproductibility of urodynamic : Pressure maximum | Reproductibility of Pressure Maximum (in cmH2O) in the three cystometries evaluated using an intra class correlation | 1 Day : during the urodynamic assessment | |
Primary | Reproductibility of urodynamic : Pressure of the first involuntary detrusor contraction (IDC) | Reproductibility of pressure of the first involuntary detrusor contraction (in cmH2O) in the three cystometries evaluated using an intra class correlation | 1 Day : during the urodynamic assessment | |
Primary | Reproductibility of urodynamic : volume of filling for the first IDC | Reproductibility of volume of filling for the first involuntary detrusor contraction (in cmH2O) in the three cystometries evaluated using an intra class correlation | 1 Day : during the urodynamic assessment | |
Secondary | Comparaison of urodynamic parameters between naive treatment patient and non naive treatment patients | Comparaison urodynamic parameters (CCM, Maximum pressure, volume filling of the first IDC, pressure of the first IDC) using a T student test | 1 Day : during the urodynamic assessment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |